Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Aya, Haggiagi"'
Autor:
Alexander H. C. W. Agopyan-Miu, Matei A. Banu, Michael L. Miller, Christopher Troy, Gunnar Hargus, Peter Canoll, Tony J. C. Wang, Neil Feldstein, Aya Haggiagi, Guy M. McKhann
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-9 (2021)
Abstract Infratentorial oligodendrogliomas, a rare pathological entity, are generally considered metastatic lesions from supratentorial primary tumors. Here, we report the case of a 23-year-old man presenting with a histopathologically confirmed righ
Externí odkaz:
https://doaj.org/article/89faa0c82cd0471e860b8a9928295171
Autor:
Meghna S. Trivedi, Melissa K. Accordino, Fabio M. Iwamoto, Deanna Fisher, Lan Huynh, Kathleen Fenn, Julie Ann Mayer, Kevin Kalinsky, Dawn L. Hershman, Julia E. McGuinness, David Cieremans, Edgar V. Sales, Mary Welch, Margaux Wooster, Robbie Schultz, Shing Lee, Lauren Franks, Teri N. Kreisl, Andrew B. Lassman, Katherine D. Crew, Veena M. Singh, Aya Haggiagi
Publikováno v:
Clin Breast Cancer
Diagnosis of LM is limited by low sensitivity of cerebrospinal fluid (CSF) cytopathology. Detecting tumor cells in CSF (CSF-TCs) might be more sensitive. We evaluated if CNSide (CNSide), a novel assay for tumor cell detection in CSF, can detect CSF-T
Autor:
Carlen A, Yuen, Jing-Mei, Hsu, Koen, Van Besien, Ran, Reshef, Fabio M, Iwamoto, Aya, Haggiagi, Benjamin, Liechty, Cenai, Zhang, Sarah F, Wesley, Rajiv, Magge
Publikováno v:
Journal of Immunotherapy. 45:254-262
Secondary central nervous system lymphoma (SCNSL) is associated with poor prognosis and new therapeutic approaches are needed. The pivotal trial that led to US Food and Drug Administration (FDA) approval of axicabtagene ciloleucel excluded patients w
Autor:
Christopher Troy, Tony J. C. Wang, Peter Canoll, Aya Haggiagi, Michael L. Miller, Gunnar Hargus, Matei Banu, Guy M. McKhann, Alexander H. C. W. Agopyan-Miu, Neil A. Feldstein
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-9 (2021)
Acta Neuropathologica Communications
Acta Neuropathologica Communications
Infratentorial oligodendrogliomas, a rare pathological entity, are generally considered metastatic lesions from supratentorial primary tumors. Here, we report the case of a 23-year-old man presenting with a histopathologically confirmed right precent
Publikováno v:
Hematological Oncology. 38:817-822
Mantle cell lymphomas (MCLs) are the prototypic B-cell non-Hodgkin lymphomas defined by cyclin D1 gene (CCND1; or other cyclin D family gene) rearrangements. However, extremely rare cases of diffuse large B-cell lymphomas (DLBCLs) harboring CCND1 rea
Publikováno v:
Current Oncology Reports
Purpose of Review Elderly patients with newly diagnosed glioblastoma (eGBM) carry a worse prognosis compared with their younger counterparts. eGBM garners special attention due to the unique challenges, including increased treatment-associated toxici
Autor:
Koen van Besien, Sarah Flanagan Wesley, Aya Haggiagi, Ran Reshef, Rajiv Magge, Carlen Yuen, Jingmei Hsu, Fabio M. Iwamoto
Publikováno v:
Neuro Oncol
INTRODUCTION Patients with secondary CNS lymphoma (SCNSL) were excluded from the pivotal trials that led to the approval of chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory (R/R) B-cell lymphomas due to concern for neurotoxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d620bcd68c076656810286199b84ac2
https://europepmc.org/articles/PMC8598798/
https://europepmc.org/articles/PMC8598798/
Publikováno v:
Clinics and Practice, Vol 5, Iss 2 (2015)
Symptomatic intracerebral hemorrhage (sICH) occurs in up to 7% of stroke patients treated with thrombolytic therapy. There are limited data on the effectiveness of the reversal agents used for intravenous tissue plasminogen activator related intracra
Externí odkaz:
https://doaj.org/article/ceca1cb7eb9840908923c1d73fa5bdb6
Publikováno v:
Neuro-Oncology. 24:vii6-vii6
INTRODUCTION Multiply recurrent glioblastoma suffers from poor response rates to treatment, and limited durability. We describe a case of an impressive response to third-line CCNU/TMZ. BACKGROUND Headaches brought a 76-year-old man to medical attenti
Publikováno v:
Neuro-Oncology. 24:vii204-vii204
INTRODUCTION Papillary tumor of the pineal region (PTPR) is a very rare tumor comprising < 1% of all intracranial neoplasms. It was first included as a distinct tumor entity in the 2007 World Health Organization classification. Due to its rarity, onl